Predictors of mortality in cancer patients who need intensive care unit support: a two center cohort study

Predictors of mortality in cancer patients who need intensive care unit support: a two center cohort study

Background/aim: Cancer patients frequently need intensive care support due to respiratory failure. We aimed to evaluate the predictorsof mortality in cancer patients who were admitted to the intensive care unit (ICU).Materials and methods: This study was performed in the ICUs of two centers between 1 January 2008 and 31 December 2015.Demographic data, cancer type, causes of respiratory failure, comorbidities, APACHE II scores, treatments, and mortality rates wererecorded.Results: A total number of 583 cancer patients (477 males) were enrolled from the two centers. Of those, 472 patients had lung cancer(81%), while 111 had extrapulmonary malignancies (19%), having similar mortality rates. Causes of respiratory failure were mostlyinvasion of the cancer itself in 84% of cases and due to infection in 12%. ICU mortality rate was 53% and the 1-year mortality rate was80%. APACHE II scores were significantly higher in nonsurvivors (P < 0.001). One-year survival was found to be significantly shorterin females than males (9 days vs. 12 days) in patients with lung cancer.Conclusion: Mortality rates of cancer patients who need ICU support are higher than overall ICU mortality. High APACHE II scoresand female sex seem to be related to mortality in these patients.

___

  • Azevedo LCP, Caruso P, Silva UVA, Torelly AP, Silva E, Rezende E, Netto JJ, Piras C, Lobo SMA, Knibel MF et al. Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study. Chest 2014; 146: 1-36.
  • Soares M, Salluh JIH, Torres VBL, Leal JVL, Spector N. Shortand long-term outcomes of critically ill patients with cancer and prolonged ICU length of stay. Chest 2008; 134: 520-526.
  • Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 2006; 32: 3-5.
  • Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160: 1957-1961.
  • Larche J, Azoulay E, Fieux F, Mesnard L, Moreau D, Thiery G, Darmon M, Le Gall JR, Schlemmer B. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003; 29: 1688-1695.
  • Thiery G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Levy V, Fieux F, Moreau D, Le Gall JR, Schlemmer B. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406- 4413.
  • Reichner CA, Thompson JA, O’Brien S, Kuru T Anderson ED. Outcome and code status of lung cancer patients admitted to the medical ICU. Chest 2006; 130: 719-723.
  • Roques S, Parrot A, Lavole A, Ancel PY, Gounant V, Djibre M, Fartoukh M. Six-month prognosis of patients with lung cancer admitted to the intensive care unit. Intensive Care Med 2009; 35: 2044-2050.
  • Andrejak C, Terzi N, Thielen S, Bergot E, Zalcman G, Charbonneau P, Jounieaux V. Admission of advanced lung cancer patients to intensive care unit: a retrospective study of 76 patients. BMC Cancer 2011; 11: 159.
  • Lin YC, Tsai YH, Huang CC, Hsu KH, Wang SW, Tsao TC, Lin MC. Outcome of lung cancer patients with acute respiratory failure requiring mechanical ventilation. Respir Med 2004; 98: 43-51.
  • Boussat S, El’rini T, Dubiez A, Depierre A, Barale F, Capellier G. Predictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Med 2000; 26: 1811-1816.
  • Ewer MS, Ali MK, Atta MS, Morice RC, Balakrishnan PV. Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure. JAMA 1986; 256: 3364-3366.
  • Adam AK, Soubani AO. Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit. Eur Respir J 2008; 31: 47-53.
  • Soares M, Darmon M, Salluh JIF, Ferreria CG, Thiery G, Schlemmer B, Spector N, Azoulay E. Prognosis of lung cancer patients with life-threatening complications. Chest 2007; 131: 840-846.
  • Roques S, Parrot A, Lavole A, Ancel PY, Gounant V, Djibre M , Fartoukh M. Six-month prognosis of patients with lung cancer admitted to the intensive care unit. Intensive Care Med 2009; 35: 2044-2050.
  • Azoulay E, Thiery G, Chevret S, Moreau D, Darmon M, Bergeron A, Yang K, Meignin V, Ciroldi M, Le Gall JR et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004; 83: 360-370.
  • Slatore CG, Cecere LM, Leteurneau JL, O’Neil ME, Duckart JP, Wiener RS, Farjah F, Cooke CR. Intensive care unit outcomes among patients with lung cancer in the Surveillance, Epidemiology, and End Results–Medicare registry. J Clin Oncol 2012; 30: 1686-1691.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Detection of the differences in the apparent diffusion coefficient values in different histopathological types of malignant breast lesions and comparison of cellular region/ stroma ratio and histopathological results

Işıl BAŞARA AKIN, Merih Güray DURAK, Ali İbrahim SEVİNÇ, Pınar BALCI, Ayça ERŞEN DANYELİ, Nevin KÖREMEZLİ KESKİN, Esra YAVUZ GÜRKAN

Leman Tekin ORGUN, Ebru ARHAN, Kürşad AYDIN, Tunzale RZAYEVA, Tuğba HIRFANOĞLU, AYŞE SERDAROĞLU

Aykut ÇİLLİ, Abdullah SAYINER, Burcu ÇELENK, Ayşin Şakar COŞKUN, Oğuz KILINÇ, Armağan HAZAR, Anil Aktaş SAMUR, Sezai TAŞBAKAN, Grant W. WATERER, Yavuz HAVLUCU, Öznur KILIÇ, Fatma TOKGÖZ, Uğur BİLGE

The in vitro effect of antimicrobial photodynamic therapy on Candida and Staphylococcus biofilms

Ayse KALKANCI, Kayhan ÇAGLAR, Merve ERDOĞAN, Elif Ayca UNAL, Olkar ABDULMAJED, Özlem GÜZEL TUNCCAN, Murat DİZBAY

Takayasu arteritis: an update

Haner DİRESKENELİ, Kenan AKSU, Gökhan KESER

Peripheral arterial disease increases the risk of multidrug-resistant bacteria and amputation in diabetic foot infections

Murat DİZBAY, Kenan HIZEL, Pınar AYSERT YILDIZ, Tuğba ÖZDİL, Özlem GÜZEL TUNÇCAN

Antibiotic treatment outcomes in community-acquired pneumonia

Sezai TAŞBAKAN, Ayşın ŞAKAR COŞKUN, Uğur BİLGE, Abdullah SAYINER, Aykut ÇİLLİ, Öznur KILIÇ, Yavuz HAVLUCU, Fatma TOKGÖZ, Anıl AKTAŞ SAMUR, Grant W. WATERER, Oğuz KILINÇ, Armağan HAZAR, Burcu ÇELENK

Cytoplasmic abnormalities of mature oocytes have a significant effect on fertilization in Bologna poor responders

Esra AKDENİZ, Halenur BOZDAĞ, Belgin DEVRANOĞLU, Murat HAKSEVER, Bülent Emre BİLGİÇ, Hüseyin Tayfun KUTLU

Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/ refractory multiple myeloma: a real-life experience

Mahmut TÖBÜ, Filiz VURAL, Murat TOMBULOĞLU, Ayşe UYSAL, Fahri ŞAHİN, Güray SAYDAM, Püsem PATIR, Hatice Demet ÜNAL, Nur SOYER, Mustafa DURAN, Raika DURUSOY

Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma

Ahmet TEKTEMUR, Ebru ÖNALAN, Süleyman Serdar KOCA, Ahmet YILDIRIM, Servet YOLBAŞ, Sibel OYUCU ORHAN, Nevzat GÖZEL, İbrahim Hanifi ÖZERCAN